GlassScriptPhysician profile
Shanda Hill
NPI 1114468832
$687.48
in general payments reported to CMS, 2019-2025
13 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.44 · 2022: $44.00 · 2023: $111 · 2024: $174 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $135.06 | 2021-2024 | Nexplanon |
| Biogen, INC. | $132.60 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $105.80 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Astrazeneca Pharmaceuticals LP | $65.74 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.03 | 2022-2025 | |
| Coopersurgical, INC. | $37.11 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Evofem Biosciences, INC. | $34.04 | 2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $28.00 | 2024 | |
| Daiichi Sankyo INC. | $22.50 | 2024 | Injectafer |
| Merck Sharp & Dohme LLC | $20.70 | 2025 | Gardasil 9 |
| Smith+Nephew, INC. | $19.29 | 2025 | Pico 14, Pico 7 |
| Millicent US INC | $18.06 | 2025 | Femlyv |
| Exeltis, USA INC. | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanda Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.